Sponsor Pipeline

ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07471880 A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage… Osteonecrosis Active, Not Recruiting
Phase 1
NCT07652372 Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis Knee Osteoarthritis Enrolling by Invitation
Get alerts when ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free